Between April 2025 and March 2026, 36.6% of samples submitted to the Welsh Emerging Drug Identification Service (Wedinos) contained something other than what the buyer expected. Concern about finding orphine analogues, nitazenes, novel benzodiazepines and more is not confined to Wales. Joseph Janes of Swansea University explained in The Conversation.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
